moxifloxacin has been researched along with sulfamethoxazole in 10 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (sulfamethoxazole) | Trials (sulfamethoxazole) | Recent Studies (post-2010) (sulfamethoxazole) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 5,813 | 680 | 1,216 |
| Protein | Taxonomy | moxifloxacin (IC50) | sulfamethoxazole (IC50) |
|---|---|---|---|
| Dihydropteroate synthase | Escherichia coli K-12 | 4.7 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 4.7 | |
| Dihydrofolate reductase | Pneumocystis carinii | 0.1 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, KL; Patel, R; Piper, KE; Reichert, EJ | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Cai, X; Cui, J; Ni, W; Wei, C; Zhao, J | 1 |
| Berjeaud, JM; Crapart, S; Crépin, A; Ecale, F; El Houari, A; Laparre, J; Ramnath, M; Rodier, MH | 1 |
| Akbar, N; Jabri, T; Kawish, M; Khan, NA; Shah, MR; Siddiqui, R | 1 |
10 other study(ies) available for moxifloxacin and sulfamethoxazole
| Article | Year |
|---|---|
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; DNA, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Penicillin-Binding Proteins; Penicillins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus; Tetracycline | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Topics: Anti-Infective Agents; Ceftazidime; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Stenotrophomonas maltophilia; Sulfamethoxazole; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
In vitro sensitivity of 30 anaerobic bacterial strains of the human intestinal core microbiota to antibiotics: Culture and LC-MS/MS approaches.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Gastrointestinal Microbiome; Humans; Mass Screening; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Sulfamethoxazole; Tandem Mass Spectrometry | 2021 |
Enhancing efficacy of existing antibacterials against selected multiple drug resistant bacteria using cinnamic acid-coated magnetic iron oxide and mesoporous silica nanoparticles.
Topics: Anti-Bacterial Agents; Cefixime; Cinnamates; Escherichia coli; Ferric Compounds; Humans; Lactate Dehydrogenases; Magnetic Phenomena; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Nanoparticles; Prospective Studies; Silicon Dioxide; Sulfamethoxazole | 2022 |